T
THNR
OtherAmplify Weight Loss Drug & Treatment ETF
$25.13+0.37 (+1.50%)CLOSE
Live · NYSE ARCA · May 13, Close
AI Insight
What's Moving THNR Today?
No stock-specific AI insight has been generated for THNR yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Market Cap$4M
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume2K
Avg Volume (10D)—
Shares Outstanding170K
THNR News
7 articles- 3 Ways to Invest in the Growing GLP-1 Weight Loss MarketMarketbeat·Apr 17, 2026
- FDA Clears NVO's Higher Dose of Wegovy: Diversify With These Health ETFsYahoo Finance·Mar 23, 2026
- Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales OutlookYahoo Finance·Feb 4, 2026
- The Obesity Pill Rush: Healthcare ETFs to Gain as FDA Nods to Novo DrugYahoo Finance·Dec 29, 2025
- Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest inYahoo Finance·Nov 24, 2025
- NVO Wins FDA Approval for MASH Treatment: ETFs Likely to GainYahoo Finance·Aug 19, 2025
- Weight-Loss Drug ETFs Generate Skinnier Returns Than ExpectedThedailyupside·Jun 11, 2025
All 7 articles loaded
Price Data
Open$24.69
Previous Close$24.76
Day High$24.76
Day Low$24.69
52 Week High—
52 Week Low—
Fundamentals
Market Cap$4M
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume2K
Avg Volume (10D)—
Shares Outstanding170K
About Amplify Weight Loss Drug & Treatment ETF
Amplify Weight Loss Drug & Treatment ETF (THNR) · Other
Listed May 20, 2024
Company Details
Security TypeETF
ExchangeNYSE ARCA
Currency—
Round Lot—
SIC—
CIK—
Composite FIGI—
Share Class FIGI—